uh 301 has been researched along with hydroxyindoleacetic acid in 1 studies
Studies (uh 301) | Trials (uh 301) | Recent Studies (post-2010) (uh 301) | Studies (hydroxyindoleacetic acid) | Trials (hydroxyindoleacetic acid) | Recent Studies (post-2010) (hydroxyindoleacetic acid) |
---|---|---|---|---|---|
52 | 0 | 8 | 8,911 | 322 | 594 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arborelius, L; Hacksell, U; Höök, BB; Nomikos, GG; Svensson, TH | 1 |
1 other study(ies) available for uh 301 and hydroxyindoleacetic acid
Article | Year |
---|---|
The 5-HT1A receptor antagonist (S)-UH-301 decreases dopamine release in the rat nucleus accumbens and striatum.
Topics: 3,4-Dihydroxyphenylacetic Acid; 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Corpus Striatum; Dopamine; Homovanillic Acid; Hydroxyindoleacetic Acid; Injections, Subcutaneous; Male; Microdialysis; Nucleus Accumbens; Rats; Rats, Wistar; Serotonin Antagonists; Serotonin Receptor Agonists | 1996 |